Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Personnel

Foresite Capital Strengthens Investor Relations and Business Development Teams with Addition of Hadi Tabbaa as Managing Director


Foresite Capital, a multi-stage healthcare and life sciences investment firm, announces today the appointment of Hadi Tabbaa as managing director of investor relations and business development. With more than two decades of experience in investor relations, capital formation and corporate business development, Hadi will oversee these efforts at Foresite, working closely with Foresite Capital CEO Jim Tananbaum and the current investor relations team to deepen the company's relationships with existing and prospective investors.

Tabbaa joins Foresite Capital from B Capital, where he was a partner and global head of investor relations. Prior to B Capital, Tabbaa was a senior member of the investor relations and marketing team at Coatue Management and served as director of institutional client coverage at Blackrock. Earlier in his career, Tabbaa was a consultant with McKinsey and an investment banker at Lehman Brothers. Mr. Tabbaa holds a B.A. in Economics and Political Science from Rice University and earned his JD at Stanford Law School.

"Hadi's diverse experience in corporate strategy, law, finance and investor relations will benefit the firm in countless ways and make him the ideal candidate to lead our client coverage efforts," said Jim Tananbaum, founder and CEO of Foresite Capital.

"Having known and admired Jim and Foresite Capital for years, I'm thrilled to join such a talented and experienced team. I look forward to strengthening our investor partnerships and building a world-class investor relations and business development function here," Mr. Tabbaa added.

About Foresite Capital

Foresite Capital is a multi-stage healthcare and life sciences investment firm with approximately $3.5 billion in assets under management. The firm aims to address areas of great unmet need by funding promising healthcare and life sciences businesses at all stages of their life cycles. Foresite Capital uses a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. Founded in 2011, Foresite Capital is based in the San Francisco Bay Area, Los Angeles and New York City. For more information, please visit www.foresitecapital.com.


These press releases may also interest you

at 17:50
The global breast tissue expander market size is estimated to grow by USD 282.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  6.78%  during the forecast period. Increasing prevalence of breast cancer is...

at 17:50
The global sleep apnea implants market size is estimated to grow by USD 401.75 thousand from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.2% during the forecast period. Increasing prevalence of sleep apnea and...

at 17:45
The global implantable medical devices market size is estimated to grow by USD 53.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.08% during the forecast period. Rise in number of people with chronic...

at 17:35
The global transplant box market size is estimated to grow by USD 2.39 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  10.87%  during the forecast period. Increasing prevalence of chronic disorders is...

at 17:31
DelveInsight's BK Virus Infection Market Insights report includes a comprehensive understanding of current treatment practices, BK virus infection emerging drugs, market share...

at 17:30
The global dermatology devices market  size is estimated to grow by USD 154.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  9.45%  during the forecast period.  Increasing prevalence of skin...



News published on and distributed by: